This book presents the role of food bioactives in cancer prevention and management, with a focus on nutraceuticals and functional foods as promising therapeutic approaches. It explores the molecular mechanisms by which bioactive compounds influence cancer cell behavior, including their impact on apoptosis, angiogenesis, inflammation, oxidative stress, and epigenetic modifications. The book covers a wide spectrum of bioactive compounds such as polyphenols, flavonoids, carotenoids, alkaloids, probiotics, and prebiotics, discussing their sources, bioavailability, metabolism, and therapeutic efficacy. It integrates findings from in vitro studies, animal models, clinical trials, and epidemiological research to provide a well-rounded perspective on the potential of functional foods in cancer prevention and treatment. Regulatory frameworks, safety concerns, and formulation challenges associated with translating nutraceutical research into clinical practice are also discussed. Additionally, it highlights the recent advancements in biotechnology and bioinformatics that enable precision nutrition approaches tailored to individual cancer risk profiles. The synergy between conventional cancer therapies and bioactive dietary compounds offers insights into how functional foods can enhance treatment efficacy and mitigate side effects.

Contributions from experts in food science, oncology, pharmacology, and public health ensure a multidisciplinary perspective on this rapidly evolving field. The book provides valuable insights for researchers, healthcare professionals, nutritionists, pharmacologists, regulatory bodies, and industry professionals involved in the development of functional food products and nutraceutical interventions for cancer management.

Dr. Syed Amir Ashraf is a researcher in food science and nutrition, affiliated with the Department of Food Technology, School of Interdisciplinary Sciences and Technology (SIST), Jamia Hamdard, New Delhi, India. His research focuses on nutraceuticals, functional foods, food safety,  metabolic disorders, cancer, and computational biology.